-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 07, 2025.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 785 in its research report dated May 22, 2025.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 760 in its research report dated February 11, 2025.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 710 in its research report dated November 10, 2024.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 515 in its research report dated August 08, 2024.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 515 in its research report dated May 26, 2024.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 400 in its research report dated November 12, 2023.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 365 in its research report dated August 07, 2023.
-
ICICI Securities is bullish on Fortis Healthcare recommended buy rating on the stock with a target price of Rs 390 in its research report dated August 08, 2023.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 365 in its research report dated June 22, 2023.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 330 in its research report dated May 24, 2023.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 360 in its research report dated February 13, 2023.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 360 in its research report dated November 14, 2022.
-
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 330 in its research report dated August 09, 2022.
-
SPA Securities is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 200 in its research report dated January 06, 2020.
-
ICICI Securities is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 160 in its research report dated August 15, 2020.
-
ICICI Securities is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 153 in its research report dated June 18, 2020.
-
Motilal Oswal is bullish on Fortis Healthcare has recommended Buy rating on the stock with a target price of Rs 185 in its research report dated March 01, 2018.
-
Motilal Oswal recommended buy rating on Fortis Healthcare with a target price of Rs 220 in its research report dated August 5, 2017.
-
Motilal Oswal is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 240 in its research report dated June 20, 2017.
-
Motilal Oswal is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 250 in its research report dated April 21, 2017.
-
Axis Direct recommended hold rating on Fortis Healthcare with a target price of Rs 198 in its research report dated February 21, 2017.
-
Sharekhan has advised investors to book profit in Fortis Healthcare with 30% gains and look for better entry points even for investment with a slightly longer term horizon, in its research report dated February 24, 2015.
-
IIFL is bullish on Fortis Healthcare and has recommended buy rating on the stock with a target of Rs 173 in its July 13, 2011 research report.
-
Aditya Birla Money is bullish on Fortis Healthcare and has recommended buy rating on the stock with a target of Rs 171 in its April 5, 2011 research report.
